A technological solution for the management of diabetes in people who require intensive
insulin therapy has been sought for decades. The last 10 years have seen substantial …

The class of rapid‐acting insulin analogues were introduced more than 20 years ago to
control postprandial plasma glucose (PPG) excursions better than unmodified regular …

Introduction Automated insulin delivery (AID) systems, known as artificial pancreas or closed-
loop glucose control systems, have been developed to improve the glycemic outcomes of …

The first insulin preparation injected in humans in 1922 was short-acting, extracted from
animal pancreas, contaminated by impurities. Ever since the insulin extracted from animal …

Introduction We investigated the safety of, and glucose control by, the insulin-only
configuration of the iLet® bionic pancreas delivering fast-acting insulin aspart (faster aspart) …

Fast-acting insulin aspart (faster aspart) is an ultra-rapid-acting formulation of insulin aspart
developed to more closely match the prandial endogenous insulin profile, and its …

Fully automated closed‐loop insulin delivery may offer a novel way to manage diabetes in
hospital. However, postprandial glycaemic control remains challenging. We aimed to assess …

Background A new era in medicine will arise due to artificial intelligence (AI). However,
current technology for AI systems does not yet allow for interaction with a patient and thus is …

Efficacy and safety of a combination of miglitol, metformin and insulin aspart in the treatment
of type 2 diabetes Page 1 Ke et al Trop J Pharm Res, October 2021; 20(10): 2171 Tropical …

A consensus report of a particular topic contains a comprehensive examination and is
authored by an expert panel (ie, consensus panel) and represents the panel's collective …